Chronic hepatitis B infection: New approaches towards cure
Chronic hepatitis B virus (HBV) infection leads to the development of cirrhosis and
hepatocellular carcinoma. Lifelong treatment with nucleotides/nucleoside antiviral agents is …
hepatocellular carcinoma. Lifelong treatment with nucleotides/nucleoside antiviral agents is …
Tenofovir vs Entecavir among patients with HBV-related HCC after resection
P Li, Y Wang, J Yu, J Yu, Q Tao, J Zhang… - JAMA Network …, 2023 - jamanetwork.com
Importance Tenofovir disoproxil and entecavir are both commonly used first-line antiviral
treatments, but their comparative recurrence and overall survival (OS) benefits remain …
treatments, but their comparative recurrence and overall survival (OS) benefits remain …
Chronic viral hepatitis B and C outweigh MASLD in the associated risk of cirrhosis and HCC
Background & Aims The impact of metabolic dysfunction-associated steatotic liver disease
(MASLD) on the development of cirrhosis and hepatocellular carcinoma (HCC) by chronic …
(MASLD) on the development of cirrhosis and hepatocellular carcinoma (HCC) by chronic …
Commentary: Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma (HCC) in people living with HIV: a report of two cases
C Sun, Y Wen, J Zhou - Frontiers in Oncology, 2024 - frontiersin.org
Although higher HCC incidence risk was reported among people living with HIV (PLWH)
compared to general population, it actually declined from 2001 to 2019 (1), especially …
compared to general population, it actually declined from 2001 to 2019 (1), especially …
Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease
M Michel, H Hagström, L Widman, P Nowak… - Gastro Hep …, 2024 - Elsevier
Abstract Background and Aims People living with HIV (PLWH) show a high incidence of
chronic liver disease (CLD). However, whether HIV is associated with major adverse liver …
chronic liver disease (CLD). However, whether HIV is associated with major adverse liver …
Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes
YT Chen, TI Chen, TH Yang, SC Yin… - Official journal of the …, 2022 - journals.lww.com
Methods: We enrolled 332,175 adults who participated in a health screening program
between 1997 and 2013. Participants were categorized into various subtypes, including …
between 1997 and 2013. Participants were categorized into various subtypes, including …